M. Ispikoudi et al. / European Journal of Medicinal Chemistry 45 (2010) 5635e5645
5645
aryl- N-(3-aryl-1,2,4-oxadiazol-5-yl)amines as potential therapeutic agents
for prostate cancer, Chem. Centr. J. 4 (2010) 4.
[24] K.E. Andersen, B.F. Lundt, A.S. Jørgensen, C. Braestrup, Oxadiazoles as bio-
isosteric transformations of carboxylic functionalities 2, Eur. J. Med. Chem. 31
(1996) 417e425.
[25] J.-M. Ahn, N.A. Boyle, M.T. MacDonald, K.D. Janda, Peptidomimetics and
peptide backbone modifications, Mini Rev. Med. Chem. 2 (2002) 463e473.
[26] L.B. Clapp, 1,2,4-oxadiazoles, Adv. Heterocyclic Chem. 20 (1976) 65e116.
[27] M. Ispicoudi, K.E. Litinas, K.C. Fylaktakidou, A convenient synthesis of 5-
amino-substituted 1,2,4-oxadiazole derivatives via reactions of amidoximes
with carbodiimides, Heterocycles 75 (2008) 1321e1328.
[28] D.N. Nicolaides, K.E. Litinas, I. Vrasidas, K.C. Fylaktakidou, Thermal trans-
formation of arylamidoximes in the presence of phosphorus ylides. Unex-
pected formation of 3-aryl-5-arylamino-1,2,4-oxadiazoles, J. Heterocyclic
Chem. 41 (2004) 499e503.
[29] D.N. Nicolaides, K.E. Litinas, T. Papamehael, H. Grzeskowiak, D.R. Gautam,
K.C. Fylaktakidou, An easy transformation of 2-amino-2-(hydroxyimino)
acetates to carbamoylformamidoximes, Synthesis (2005) 407e410.
[30] K.C. Fylaktakidou, K.E. Litinas, A. Saragliadis, S.G. Adamopoulos, D.N. Nicolaides,
Synthesis of oxadiazoloquinoxaline, oxathiadiazoloquinoxaline and oxadiazo-
lobenzothiazine derivatives, J. Heterocyclic Chem. 43 (2006) 579e583.
[31] R. Lenaers, F. Eloy, Etude de quelques reactions des chlorures d’acides
hydroxamiques preparation d’oxadiazoles-1,2,4 disubstitues, Helv. Chim. Acta
46 (1963) 1067.
[32] F. Eloy, R. Lenaers, Synthese d’amino-oxadiazoles-1,2,4, Helv. Chim. Acta 49
(1966) 1430e1432.
[33] C. Moussebois, F. Eloy, Etude des Proprietes Chimiques d’oxadiazoles-1,2,4
en Relation avec leur Degre d’ Aromatique, Helv. Chim. Acta 47 (1964)
838e848.
[53] E. Pontiki, D. HadjipavloueLitina, Lipoxygenases (LOs): an heterogenous
family of lipid peroxidizing enzymes implicated in cell differentiation,
inflammation, asthma, carcinogenesis, atherogenesis an interesting target for
the development of promising drugs, Curr. Enzym. Inhib. 1 (2005) 309e328.
[54] E. Pontiki, D. Hadjipavlou-Litina, Lipoxygenase inhibitors: a comparative QSAR
study review and evaluation of new QSARs, Med. Res. Rev. 28 (2008) 39e117.
[55] T.Y. Shen, in: M.E. Wolf (Ed.), Burger’s medicinal chemistry, non steroidal anti-
inflammatory agents, John Wiley & Sons, New York, 1980.
[56] C.A. Winter, in: S. Gattini, M.N.G. Dukes (Eds.), Non-steroidal anti-inflamma-
tory drugs, Excepta Medica, Amsterdam, 1965, p. 190.
[57] J.F. Kerwin Jr., L.R. Lancaster Jr., P.L. Feldman, Nitric oxide-A new paradigm for
2nd messengers, J. Med. Chem. 38 (1995) 4343e4362.
[58] L. Ignarro, F. Murad, Nitric Oxide: Biochemistry, Molecular Biology, and
Therapeutic Implications. Academic Press, San Diego, 1995.
[59] S. Moncada, R.M.J. Palmer, E.A. Higgs, Nitric oxide-physiology, pathophysi-
ology and pharmacology, Pharmacol. Rev. 43 (1991) 109e142.
[60] J.B. Hibbs Jr., R.R. Taintor, Z. Vaurin, D.L. Granger, J.C. Drapier, I.J. Amber,
J.R. Lancaster Jr., in: S. Moncada, E.A. Higgs (Eds.), Nitric oxide from l-arginine:
a bioregulatoy system, Excepta Medica, Amsterdam, 1990.
[61] E. Moilanen, H. Vapaatalo, Nitric oxide in inflammation and immune response,
Ann. Med. 27 (1995) 359e367.
[62] L. Connelly, M. Palacios-Callender, C. Ameixa, S. Moncada, A.J. Hobbs, Biphasic
regulation of NF-kB activity underlies the pro- and anti-inflammatory actions
of nitric oxide, J. Immunol. 166 (2001) 3873e3881.
[63] U.K. Bandarage, D.R. Janero, Nitric oxide-releasing nonsteroidal anti-inflam-
matory drugs novel gastrointestinal-sparing drugs, Mini Rev. Med. Chem. 1
(2001) 57e70.
[64] J.L. Wallace, Gastric ulceration: critical events at the neutrophileendothelium
interface, Can. J. Physiol. Pharmacol. 71 (1993) 98e102.
[34] V.N. Yarovenko, V.Z. Shirinyan, I.V. Zavarzin, M.M. Krayushkin, A convenient
synthesis of 3-substituted 5-guanidino-1,2,4-oxadiazoles, Russ. Chem. Bull.
Int. Ed. 43 (1994) 114e117.
[35] M. Yasumoto, K. Yanagiya, I. Shibuya, M. Goto, The synthesis of 1,2,4-oxa-
diazoles under high pressure, Nippon Kagaku Kaishi 10 (1987) 1807e1812.
[36] E. Kawashima, K. Tabei, Reaction of benzamide oxime with DCC, J. Hetero-
cyclic Chem. 23 (1986) 1657e1660.
[37] F. Eloy, R. Lenaers, The chemistry of amidoximes and related compounds,
Chem. Rev. 62 (1962) 155e183. All amidoximes were prepared according to
procedures described there.
[38] M. Adib, S. Bagherzadeh, M. Mahdavi, H.R. Bijanzadeh, An efficient one-pot
synthesis of 3-aryl-1,2,4-oxadiazol-5-amines under solvent free conditions,
Mendeleev Commun. 20 (2010) 50e51.
[65] S. Moncada, A. Higgs, Mechanism of disease: the L-arginine nitric oxide
pathway, New Eng. J. Med. 329 (1993) 2002e2012.
[66] P. Akarasereenont, J.A. Mitchell, Y.S. Bakhle, C. Thiemermann, J.R. Vane,
Comparison of the induction of cyclooxygenase and nitric-oxide synthase by
endotoxin in endothelial-cells and macrophages, Eur. J. Pharmacol. 273 (1995)
121e128.
[67] J.R. Vane, J.A. Mitchell, I. Appleton, A. Tomlinson, D. Bishop-Bailey, J. Croxtall,
D.A. Willoughby, Inducible isoforms of cyclooxygenase and nitric-oxide syn-
thase in inflammation, Proc. Natl. Acad. Sci. U.S.A. 91 (1994) 2046e2050.
[68] J.A. Corbett, G. Kwon, J. Turk, M.L. McDaniel, IL-1 beta induces the coex-
pression of both nitric oxide synthase and cyclooxygenase by islets of lang-
erhans: activation of cyclooxygenase by nitric oxide, Biochemistry 32 (1993)
13767e13770.
[39] A. Loupy, Microwaves in Organic Synthesis. Wiley-VCH, Weinheim, 2004.
[40] B. Oussaid, L. Moeini, B. Martin, D. Villemin, B. Garrigues, Improved synthesis
of oxadiazoles under microwave irradiation, Synth. Commun. 25 (1995)
1451e1459.
[69] R. Clancy, B. Varenika, W. Huang, L. Ballou, M. Attur, A.R. Amin, S.B. Abramson,
Nitric oxide synthase/COX cross-talk: nitric oxide activates COX-1 but inhibits
COX-2-derived prostaglandin production, J. Immunol. 165 (2000) 1582e1587.
[70] M. Nakatsuka, Y. Osawa, Selective inhibition of the 12-lipoxygenase pathway
[41] M. Adib, A.M. Jahromi, N. Tavoosi, M. Mahdavia, H.R. Bijanzadeh, Microwave-
assisted efficient, one-pot, three-component synthesis of 3,5-disubstituted
1,2,4-oxadiazoles under solvent-free conditions, Tetrahedron Lett. 47 (2006)
2965e2967.
[42] T. Kurz, N. Lolak, D. Geffken, Rapid and efficient microwave-assisted synthesis
of 5-amino-3-aralkoxy(methoxy)amino-1,2,4-oxadiazoles, Tetrahedron Lett.
48 (2007) 2733e2735.
[43] L.A. Saldanha, G. Elias, M.N. Gao, Oxygen radical scavenging activity of phe-
nylbutenones and their correlation with anti-inflammatory activity, Arzneim.-
Forsch./Drug Res. 40 (1990) 89e91.
of arachidonic acid metabolism by
L-arginine or sodium nitroprusside in intact
human platelets, Biochem. Biophys. Res. Commun. 200 (1994) 1630e1634.
[71] M.J. Nelson, The nitric oxide complex of ferrous soybean lipoxygenase-1.
Substrate, pH, and ethanol effects on the active-site, J. Biol. Chem. 262 (1987)
12137e12142.
[72] J.R. Galpin, G.A. Veldink, J.F.G. Vliegenthart, J. Boldingh, Interactionof nitric oxide
with soybean lipoxygenase-1, Biochim. Biophys. Acta 536 (1978) 356e362.
[73] R. Wiesner, J. Rathmann, H.G. Holzhutter, R. Stosser, K. Mader, H. Nolting,
H. Kühn, Nitric oxide oxidises a ferrous mammalian lipoxygenase to a pre-
activated ferric species, FEBS Lett. 389 (1996) 229e232.
[44] L. Flohe, R. Beckman, H. Giertz, G. Loschen, in: H. Sies (Ed.), Oxygen-centered
free radicals as mediators of inflammation, Academic Press, London, 1985.
[45] R.L. Prior, X. Wu, K. Schaich, Standardized methods for the determination of
antioxidant capacity and phenolics in foods and dietary supplements, J. Agric.
Food Chem. 53 (2005) 4290e4302.
[46] T. Kulisic, A. Radonic, V. Katalinic, M. Milos, Use of different methods for
testing antioxidative activity of oregano essential oil, Food Chem. 85 (2004)
633e640.
[47] M.S. Blois, Antioxidant determination by the use of a stable free radical,
Nature (London) 181 (1958) 1199e1200.
[48] Biobyte Corp., C-QSAR database 201 West 4th Str., Suite 204, Claremont CA,
California 91711, USA.
[49] H. Kuhn, J. Belkner, R. Wiesner, A.R. Brash, Oxygenation of biological
membranes by the pure reticulocyte lipoxygenase, J. Biol. Chem. 265 (1990)
18351e18361.
[50] M. Maccarrone, A. Baroni, A. Finazzi-Agro, Natural polyamines inhibit soybean
(glycine max) lipoxygenase-1, but not the lipoxygenase-2 isozyme, Arch.
Biochem. Biophys. 356 (1998) 35e40.
[74] H.G. Holzhutter, R. Wiesner, J. Rathmann, R. Stosser, H. Kühn, A kinetic model
for the interaction of nitric oxide with a mammalian lipoxygenase, Eur. J.
Biochem. 245 (1997) 608e616.
[75] M.J. Coffey, B. Coles, V. O’Donnell, Interactions of nitric oxide-derived reactive
nitrogen species with peroxidases and lipoxygenases, Free Radic. Res. 35
(2001) 447e464.
[76] C. Medana, G. Ermondi, R. Fruttero, A. Casco, D. Ghigo, A. Bosia, Furoxans as
nitric-oxide donors e 4-phenyl-3-furoxancarbonitrile e thiol mediated nitric
oxide release and biological evaluation, J. Med.Chem. 37 (1994) 4412e4416.
[77] L.N. Koikov, N.V. Alexeeva, E.A. Lisitza, E.S. Krichevsky, N.B. Grigoryev,
A.V. Danilov, I.S. Severina, N.V. Pyatakova, V.G. Granic, Oximes, amidoximes
and hydroxamic acids as nitric oxide donors, Mendeleev Commun. 4 (1998)
165e168.
[78] M. Feelisch, S. Schönafinger, E. Noack, Thiol mediated generation of nitric
oxide accounts for the vasodilator action of Furoxans, Biochem. Pharm 44
(1992) 1149e1157.
[79] C.A. Kontogiorgis, D.J. Hadjipavlou-Litina, Nitric oxide release from coumarin-
7-azomethine derivatives in the presence of thiol, Arzneim.-Forsch./Drug Res.
57 (2007) 143e146.
[80] M. Curini, F. Epifano, S. Genovese, L. Menghini, D. Ricci, D. Fraternale,
L. Giamperi, A. Bucchini, E. Bellacchio, Lipoxygenase inhibitory activity of
boropinic acid, active principle of Boronia pinnata, Nat. Prod. Commun. 1
(2006) 1141e1145.
[81] C. Kontogiorgis, D. Hadjipavlou-Litina, Biological evaluation of several
coumarin derivatives designed as possible anti-inflammatory/antioxidant
agents, J. Enzym. Inhib. Med. Chem. 18 (2003) 63e69.
[51] (a) I. Shureiqi, S.M. Lippman, Lipoxygenase modulation to reverse carcino-
genesis, Cancer Res. 61 (2001) 6307e6312;
(b) L. Zhao, C.D. Funk, Lipoxygenase pathways in atherogenesis, Trends Car-
diovasc. Med 14 (2004) 191e195.
[52] R.B. Taraborewala, J.M. Kauffman, Synthesis and structureeactivity relation-
ships of anti-inflammatory 9,10-dihydro-9-oxo-2-acridine alkalonic acids and
4-(2-carboxyphenyl)aminobenzene alkanoic acids, J. Pharm. Sci. 79 (1990)
173e178.